Sygnature Discovery Limited
Clare Wilson is a Senior Scientist at Sygnature Discovery, contributing to the development of therapeutics through the High-Throughput Screening Team since January 2022. Previously, Clare served as a Post-Doctoral Research Fellow at the University of Leeds DCDR for over a decade, where involvement in the design and progression of projects related to anticoagulant and antiplatelet drug development, as well as coagulation studies, was significant. Clare's academic background includes a PhD in Pharmacology and a BSc in Biochemistry with Medical Biochemistry from the University of Leeds. Early research experience includes a summer internship focused on molecular cloning and cell culture.
This person is not in any offices
Sygnature Discovery Limited
2 followers
Sygnature Discovery are a leading drug discovery CRO with expertise across a range of therapeutic and biological target classes. An expert partner in disciplines including Medicinal and Computational Chemistry, In Vitro and In Vivo Pharmacology, DMPK, supported by informatics.